Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 15

Results For "IDA"

1676 News Found

Zydus Wellness posts Q1 FY24 consolidated PAT at Rs. 110.4 Cr
News | August 04, 2023

Zydus Wellness posts Q1 FY24 consolidated PAT at Rs. 110.4 Cr

The company has reported total income of Rs. 704.5 crores during the period ended June 30, 2023


Lupin posts Q1 FY24 consolidated PAT at Rs. 452.26 Cr
News | August 04, 2023

Lupin posts Q1 FY24 consolidated PAT at Rs. 452.26 Cr

The company has reported total income of Rs. 4836.89 crores during the period ended June 30, 2023


Piramal Pharma posts Q1 FY24 consolidated loss at Rs. 98.58 Cr
News | August 04, 2023

Piramal Pharma posts Q1 FY24 consolidated loss at Rs. 98.58 Cr

The company has reported total income of Rs. 1787.16 crores during the period ended June 30, 2023


Narayana Hrudayalaya posts Q1 FY24 consolidated PAT at Rs. 183.95 Cr
News | August 03, 2023

Narayana Hrudayalaya posts Q1 FY24 consolidated PAT at Rs. 183.95 Cr

The company has reported total income of Rs. 1248.51 crores during the period ended June 30, 2023


Bliss GVS Pharma Q1 FY2024 consolidated PAT up at Rs. 14.68 Cr
News | August 02, 2023

Bliss GVS Pharma Q1 FY2024 consolidated PAT up at Rs. 14.68 Cr

The company has reported total income of Rs. 164.63 crores during the period ended June 30, 2023


Dr. Reddy's Laboratories Q1 FY2024 consolidated PAT jumps to Rs. 1402.5 Cr
News | July 28, 2023

Dr. Reddy's Laboratories Q1 FY2024 consolidated PAT jumps to Rs. 1402.5 Cr

The company has reported total income of Rs. 6738.4 crores during the period ended June 30, 2023


Astec LifeSciences posts consolidated Q1FY24 loss at Rs. 8.19 Cr
News | July 28, 2023

Astec LifeSciences posts consolidated Q1FY24 loss at Rs. 8.19 Cr

Astec LifeSciences has reported total income of Rs. 144.55 crores during the period ended June 30, 2023


Laurus Labs posts decline in Q1FY24 consolidated PAT to Rs. 24.85 Cr
News | July 28, 2023

Laurus Labs posts decline in Q1FY24 consolidated PAT to Rs. 24.85 Cr

The company has reported total income of Rs. 1185.39 crores during the period ended June 30, 2023


Dr. Lal Path Labs Q1FY24 consolidated PAT up at Rs. 82.6 Cr
News | July 28, 2023

Dr. Lal Path Labs Q1FY24 consolidated PAT up at Rs. 82.6 Cr

Dr. Lal Path Labs Ltd. has reported total income of Rs. 555.4 crores during the period ended June 30, 2023


Ajanta Pharma's Q1 FY24 consolidated PAT up at Rs. 208.12 Cr
News | July 28, 2023

Ajanta Pharma's Q1 FY24 consolidated PAT up at Rs. 208.12 Cr

The company has reported total income of Rs. 1052.79 crores during the period ended June 30, 2023